Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2001
03/07/2001EP0783505B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE
03/07/2001CN1286683A Tetrahydrobenzindole derivs
03/06/2001US6197976 Acylation, salt formation, deamination
03/06/2001US6197975 7-azabicyclo(2.2.1)heptane-7-carbonyl-substituted 2-phenylindole derivatives; sexual disorders; anticarcinogenic agents
03/06/2001US6197968 Storage stability; colorless after solution treatment
03/06/2001US6197958 Carboxylic acid derivatives, their preparation and use
03/06/2001US6197954 Intermediates for the synthesis of debromohymenialdisine and processes thereof
03/06/2001US6197804 Kinase inhibitors; anticancer agents
03/06/2001US6197785 Cardiovascular disorders
03/06/2001US6197782 Therapy for sexual disorders
03/06/2001US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
03/06/2001US6197774 Therapy for asthma, skin disorders
03/06/2001US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents
03/06/2001US6197071 Formulations for dyeing keratin fibers comprising a pyrazolotriazole coupler and oxidation base
03/06/2001CA2223081C Heterocyclic ring-fused pyrimidine derivatives
03/06/2001CA2183655C 4-polycyclic amino-substituted quinazoline derivatives
03/06/2001CA1341201C Bis-(hydroxymethyl) cyclobutyl purines and pyrimidines
03/01/2001WO2001014381A1 Ether derivatives of pyrrolo[1,2-a]quinoxalines, method for producing them and their use in therapy
03/01/2001WO2001014380A1 Isomeric fused pyrrolocarbazoles and isoindolones
03/01/2001WO2001014379A2 A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
03/01/2001WO2001014378A1 PYRROLOTRIAZINE DERIVATIVES HAVING sPLA2-INHIBITORY ACTIVITIES
03/01/2001WO2001014377A1 Imidazo-triazine derivatives as ligands for gaba receptors
03/01/2001WO2001014368A1 Compounds, compositions and methods for treating influenza
03/01/2001WO2001014333A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity
03/01/2001WO2001014288A1 Optically active isocyanurate and optical resolver comprising derivative of the same
03/01/2001WO2001013895A2 Controlled-release sedative-hypnotic compositions and methods related thereto
02/2001
02/28/2001EP1077951A1 N,n'-azobis-nitroazoles and analogs thereof as igniter compounds for use in energetic compositions
02/28/2001EP1077705A1 Potassium channel agonists
02/28/2001CN1285834A Fused pyrazine compound
02/27/2001US6194577 Oxidizing 1-aminopyrrolidine in presence of inorganic base with air, oxygen or aqueous hydrogen peroxide as an oxidizing agent to form tetrahydropyridazine
02/27/2001US6194574 Selectively bind to corticotropin-releasing factor (crf1) receptors; for treating stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety
02/27/2001US6194566 Reacting porphyrin-metal complex with metal acetylacetonate in solvent or solvent mixture selected from water, formic acid, dimethylformamide, dimethyl sufoxide, chloroform and heating to form metalloporphyrin-metal complex
02/27/2001US6194447 Bis (benzimidazole) derivatives serving as potassium blocking agents
02/27/2001US6194426 5,6,7,8 tetrahydroindolizines derivatives
02/27/2001US6194419 Therapy for sexual disorders; a 5-oxoimidazolo(1,2-a)pyrimidine-6-carboxylic ester
02/27/2001US6194416 Central nervous system disorders; alzheimer's disease
02/27/2001US6194410 Antiserotonine agents; nervous system and psychological disorders
02/27/2001CA2212784C Piperidinylamino tricyclic compounds as substance p antagonists
02/22/2001WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
02/21/2001EP1077214A1 An improved process for preparing a pyrazolopyrimidinone derivative
02/21/2001EP1076656A2 N-heteroaryl-substituted pyridine derivatives and their use as herbicides
02/21/2001EP1076655A1 N-pyridonyl herbicides
02/21/2001CN1284958A Metallocorrinoids as biologically compatible carriers of pharmocological agents
02/21/2001CN1284953A Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides
02/21/2001CN1284505A Azabicyclic compound
02/20/2001US6191285 Process for the preparation of ketorolac tromethamine
02/20/2001US6191160 Spiro-indolines as Y5 receptor antagonists
02/20/2001US6191139 Antidepressant
02/20/2001US6191131 Psychological, nervous system disorders
02/20/2001US6191070 Pyrimidinone derivatives and herbicides containing them
02/20/2001CA2223624C Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines
02/20/2001CA2192289C Substituted heterocyclic derivatives
02/15/2001WO2001010971A1 Selectively light-absorptive material, coating composition containing the same, and filter manufactured using the coating composition for color displays
02/15/2001WO2001010868A1 Synthesis of substituted pyrazolopyrimidines
02/15/2001WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof
02/15/2001WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
02/15/2001WO2001010440A1 COMPOSITIONS AND METHODS TO ENHANCE CANCER CHEMOTHERAPY IN p53 DEFECTIVE TUMORS
02/15/2001WO2000066584B1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
02/15/2001CA2381524A1 Synthesis of substituted pyrazolopyrimidines
02/15/2001CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof
02/14/2001EP1021451A4 Asymmetric synthesis and catalysis with chiral heterocyclic compounds
02/14/2001EP0944632B1 Liquid crystalline diketopyrrolopyrroles
02/14/2001EP0815120B1 17-difluoromethylene-oestratrienes
02/14/2001EP0711294B1 Use of diazapentalene derivatives as reagents specific for thiol compounds
02/14/2001CN1284084A Echinocandin derivatives, prepn. method and application as anti-fungal agents
02/14/2001CN1284079A Novel compounds
02/14/2001CN1284078A Heterocycilc compounds for inhibition of gastric acid secretion, processes for their prepn. and pharmaceutical compsns thereof
02/14/2001CN1284077A Purine derivatives having phosphodiesterase IV inhibition activity
02/14/2001CN1283624A Process for preparing 'Xidinafei' medicine
02/14/2001CN1283623A 1,2,4,5-tetrahydro-benzo[d] azepine compound
02/13/2001US6187928 Treating fungal diseases
02/13/2001US6187804 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1 -hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid, salt or hydrolysable ester thereof for example, dry blended with an alkali metal carbonate or bicarbonate
02/13/2001US6187798 Heterocyclic compounds
02/13/2001US6187778 4-aminopyrrole (3, 2-D) pyrimidines as neuropeptide Y receptor antagonists
02/13/2001US6187777 Pyrrolo(3,2-d)pyrimidine derivatives; neuropeptide y and corticotropin releasing factor modulators; dietetics; antidiabetic, antiinflammatory, and antitumor agents
02/13/2001US6187776 Heterocyclic compounds and their use
02/13/2001US6187774 Fused heterocyclic compounds and pharmaceutical applications thereof
02/13/2001US6187772 Pyrroloazepine compounds
02/13/2001CA2180977C Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light
02/13/2001CA2001203C Novel antimicrobial dithiocarbamoyl quinolones
02/08/2001WO2001009136A1 1,2-dihydro-1-oxo-pyrazino[1,2-a]indole derivatives
02/08/2001WO2001008687A1 Beta-carboline pharmaceutical compositions
02/08/2001WO2001008686A1 Beta-carboline pharmaceutical compositions
02/08/2001WO2000066528A3 Quinones for treatment of diseases
02/08/2001WO2000061783A3 Process for preparing inhibitors of nucleoside metabolism
02/08/2001CA2393915A1 1,2-dihydro-1-oxo-pyrazino¬1,2-a|indole derivatives
02/07/2001EP1074258A2 Methods and compositions for treating diseases and conditions of the eye
02/07/2001EP1073673A1 NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS
02/07/2001EP1073660A1 Yellow pteridine having a hue-angle of at least 98
02/07/2001EP1073659A1 Preparation of alkylthio- and/or arylthio-substituted diketo-diaryl-pyrrolopyrroles
02/07/2001EP1073658A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
02/07/2001EP1073644A1 Solid supported synthesis of sulfonated 2-oxopiperazines
02/07/2001EP0862624A4 Water soluble cross-linking agents
02/07/2001CN1283197A Pleuromutilin derivatives as antimicrobials
02/07/2001CN1283190A Substituted benzene compounds, process for their preparation and herbicidal and defoliant composition containing them
02/07/2001CN1282740A Intermediate compound for preparing xibo ketone
02/06/2001US6184226 Antiinflammatory agents for treatment of cardiovascular system disorders/respiratory system disorders, antiischemic agents
02/06/2001US6184223 Reverse-turn mimetics and methods relating thereto
02/06/2001US6183727 Detecting a pathology or target tissue by administering a zinc phthalocyanine dyes imaging material and exposing to radiation without damaging the mammalian host
02/06/2001CA2314798A1 1,2,4,5-tetrahydro-benzo[d]azepin derivatives